Cabaletta Bio Inc (CABA) Closes at $2.19 on Friday

Abby Carey

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.74 million shares were traded. CABA stock price reached its highest trading level at $2.2 during the session, while it also had its lowest trading level at $2.1285.

Ratios:

Our analysis of CABA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.03.

On December 20, 2024, Evercore ISI Downgraded its rating to In-line which previously was Outperform and also lowered its target price recommendation from $15 to $6. Wells Fargo Downgraded its Overweight to Equal Weight on December 19, 2024, whereas the target price for the stock was revised from $12 to $6.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 210820800 and an Enterprise Value of 76669800.

Stock Price History:

The Beta on a monthly basis for CABA is 3.23, which has changed by -0.022321403 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $3.67, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -11.75%, while the 200-Day Moving Average is calculated to be 15.18%.

Shares Statistics:

CABA traded an average of 4.01M shares per day over the past three months and 1679280 shares per day over the past ten days. A total of 96.27M shares are outstanding, with a floating share count of 84.43M. Insiders hold about 12.29% of the company’s shares, while institutions hold 64.50% stake in the company. Shares short for CABA as of 1765756800 were 18948919 with a Short Ratio of 4.72, compared to 1763078400 on 16196450. Therefore, it implies a Short% of Shares Outstanding of 18948919 and a Short% of Float of 20.02.

Earnings Estimates

The market rating for Cabaletta Bio Inc (CABA) is a result of the insights provided by 5.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.36 and low estimates of -$0.48.

Analysts are recommending an EPS of between -$1.49 and -$2.46 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.68, with 5.0 analysts recommending between -$1.17 and -$1.91.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.